Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Clinical trial NCT01079325 · COMPLETED

Trial details

NCT number: NCT01079325
Sponsor: Sangamo Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Diabetic Polyneuropathy

Start date: 2009-11-01
Primary completion: 2015-05-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.